GovChime
Notice ID: d93d54fba3954ffe9093b2fc9582e822Combined Synopsis/Solicitation

HIV Outpatient Study (HOPS) Support

Archived on August 20, 2023. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
3:00 PM UTC−04:00
Posted
July 12, 2023
Notice type
Combined Synopsis/Solicitation
NAICS
541611: Administrative Management and General Management Consulting Services
Agency
Department of Health and Human ServicesCENTERS FOR DISEASE CONTROL AND PREVENTION

Notice details

Office
CDC OFFICE OF ACQUISITION SERVICES
Place of performance
Atlanta, GA, 30341
Last updated
Dec 6, 2025

Identifiers

Solicitation number
75D301-23-R-72693
Notice ID
d93d54fba3954ffe9093b2fc9582e822

Description

Attaching answers to questions submitted re. RFP, and an updated Statement of Work which specifies due dates for deliverables associated with Subtask 6.4. Combined Synopsis/Solicitation for HIV Outpatient Survey (HOPS) support services as detailed in the statement of work (Attachment 2). To be considered responsive, a Subcontracting Plan shall be submitted to the HHS SBCX platform prior to the proposal response deadline at the following URL: https://osdbu.hhs.gov/subcontracting/1a30a506-4e29-4503-9b02-0b36208bb344 Please see the solicitation for futher specific instructions.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75D301-23-R-72693
  1. Combined Synopsis
  1. 5×
    Combined SynopsisCurrentJul 5, 2023

    HIV Outpatient Study (HOPS) Support

    Notice d93d54fba3954ffe9093b2fc9582e822 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
The Centers for Disease Control and Prevention (CDC) awarded a sole source contract with MATHEMATICA INC., 1100 1ST ST NE FL 12, WASHINGTON, DC. 20002 This notice is provided in accordance with RFO FAR 8.401 & GSAM/R 538.7104-3(b)(1) . Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases (DBD) requires support Services with the contractor listed above. The requested contractor Mathematica qualified as “innovator status” vendor for data analysis by Center for Medicare and Medicaid Services (CMS). Mathematica also has demonstrated experience and specialized staff with unique access and analytical capabilities for Medicaid data sets which captures the largest segment of US healthcare data, including births. The contractor shall perform analyses across four technical dimensions defined in the Statement of Work: (1) validating infant GBS case counts using TAF OT claims and evaluating a fourth case definition tied to maternal Medicaid IDs; (2) developing and refining a probabilistic mother-infant linkage algorithm using the Medicaid Case Number and supplementary variables; (3) estimating maternal vaccination coverage (COVID-19, influenza, Tdap, and prospectively RSV) accounting for bundled payment code effects; and (4) applying methods to reduce gestational age missingness using prenatal claims data. These tasks require continuity with linkage algorithms and case-definition logic Mathematica has already built and validated under prior CDC task orders. The authority permitting other than full and open competition is Title III of the Federal Property and Administrative Services Act of 1949 (41 U.S.C. 251, et seq.); Title 40 U.S.C. 501, Services for Executive Agencies, as implemented at FAR 8.401 and GSAM/R 538.7104-3(b)(1) "Only one source is capable of providing the products, services, or solution required at the level of quality required because the products, services, or solutions are unique or highly specialized." Through its prior contracts, Mathematica has already built key parts of this analysis—including updating the medical codes used to identify cases, working to link mother and infant records more completely, and adjusting for how individual states handle Medicaid enrollment for newborns. This steady, hands-on progress means Mathematica starts this next phase of work already ahead, with the knowledge and tools in place that a new contractor would not have. All responsible sources may submit a capability statement, proposal, or quotation to Robin C. Meyer, Contract Specialist, at rcm2@cdc.gov, which shall be considered by the agency. The deadline for submissions is Ocotber 31, 2026 at 4:30PM EST. The Government will review any/all information submitted to determine if other responsible sources exist that could provide this requirement. Information received in response to this announcement will be used solely for the purpose of determining whether to conduct a competitive procurement.
-Special Notice10/31/2026
This presolicitation notice is prepared in accordance with Revolutionary FAR Overhaul 5.101. (1) Points of contact. H. Dale Bish: uwo8@cdc.gov; 404.498.1312 Henrietta Fumbah: ehu0@cdc.gov, 770.488.8239 (2) Set-asides. Small business set-asides are applicable by domain. Domain 1: 25% Small Business Set-Aside (Partial Small Business Set-Aside) Domain 2: 25% Small Business Set-Aside Aside (Partial Small Business Set-Aside) Domain 3: 25% Small Business Set-Aside Aside (Partial Small Business Set-Aside) Domain 4: 25% Small Business Set-Aside Aside (Partial Small Business Set-Aside) Domain 5: 100% Small Business Set-Aside (Total Small Business Set-Aside) (3) Codes for services or supplies. The following NAICS codes and size standards are anticipated: NAICS 541690 Other Scientific and Technical Consulting Services ($19M) NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (1,000 Employees) NAICS 611430 Professional and Management Development Training ($15M) (4) Description. (i) The Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Healthcare Quality Promotion (DHQP), announces its intent to compete a new Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract vehicle titled “Safety, Prevention, Epidemiology, and Education Development for Health Care and Antimicrobial Resistance (SPEED).” SPEED will provide CDC with an "as needed" mechanism to obtain healthcare epidemiology, health behavior, and healthcare-associated infection research support across five functional domains: (1) Domestic Antimicrobial Resistance, Infection Prevention and Control, and Adverse Events Services; (2) Healthcare Information Technology and Data Solutions Services; (3) Global Antimicrobial Resistance and Infection Prevention and Control Services; (4) Emergency Preparedness, Response Services, and Healthcare System Resilience Services; and (5) Workforce Training, Message Development, Dissemination, and Testing Services. The anticipated ordering period (period of performance) for the SPEED IDIQ is a 60-month period beginning on March 30, 2027 and ending March 29, 2032. Offerors may submit proposals to one or more domains and will be evaluated on technical approach including existing infrastructure and capacity, staffing approach, management approach, similar experience, price, and past performance. To ensure continuity of critical healthcare epidemiology and infection prevention research support with no lapse in service, DHQP extended the current Safe Healthcare, Epidemiology, Prevention Research Development (SHEPheRD) Program contracts through March 29, 2027, the day immediately preceding the SPEED anticipated effective start date. This extension allows CDC to maintain uninterrupted access to essential scientific, technical, and programmatic support while the SPEED solicitation, evaluation, and award process is completed. DHQP intends for SPEED to fully replace SHEPheRD upon award. CDC will provide further information regarding the solicitation timeline, evaluation criteria, and instructions for interested offerors in forthcoming notices. Interested parties are encouraged to monitor SAM.gov for the official solicitation and any applicable updates. SPEED shall consist of 5 Domains briefly described as follows: Domain 1: Domestic Antimicrobial Resistance, Infection Prevention and Control, and Adverse Events Services. The purpose of this domain is to obtain services that support the design, execution, and assessment of healthcare and community epidemiology research initiatives addressing antimicrobial resistance (AR), infection prevention and control (IPC), and adverse events domestically within U.S. healthcare settings and communities. These implementation services include developing and implementing study protocols, conducting clinical and epidemiologic investigations, evaluating outcomes, and translating research findings into scalable, evidence-based public health interventions. Domain 2: Healthcare Information Technology and Data Solutions Services The purpose of this domain is to obtain services for the development and deployment of digital health systems, advanced analytics, Artificial Intelligence (AI) and machine learning-driven tools, and mathematical modeling to strengthen surveillance, automate data processing, improve data quality, and enhance decision-making across health programs. This includes the ability of Offerors to develop, implement, or maintain healthcare or ancillary medical (e.g., laboratory, pharmacy, etc.) surveillance systems, deploy natural language processing applications and other artificial intelligence tools, conduct human factors engineering, and apply mathematical modeling to optimize system usability, workflow efficiency, and data interpretation Domain 3: Global Antimicrobial Resistance and Infection Prevention and Control Services The purpose of this domain is to obtain services for development and implementation of research projects and protocols focused on antimicrobial stewardship, antimicrobial resistance detection and control, global health coordination, surveillance, and prevention of healthcare-associated infections in global healthcare settings. These tasks include, but are not limited to, conducting program evaluations, clinical investigations, cost effectiveness and disease modeling analyses, and translating findings into scalable and sustainable public health interventions with a particular focus on low- and middle-income countries. Domain 4: Emergency Preparedness, Response Services, and Healthcare System Resilience Services The purpose of this domain is to obtain services to rapidly respond to healthcare quality and safety threats. Services that may be conducted under this domain include supporting CDC's ability to respond effectively and rapidly to outbreaks, emergencies, and public health threats during times of healthcare facility or health system stress or strain. Domain 5: Workforce Training, Message Development, Dissemination and Testing Services The purpose of this domain is to obtain services that strengthen the capacity, knowledge, and preparedness of healthcare workers, public health personnel (including CDC staff), and the general public to prevent infections and reduce the spread of antimicrobial resistance and other infectious disease threats. (ii) Applicable World Trade Organization Government Procurement Agreement (WTO GPA) and/or a Free Trade Agreement (FTA) (see Part 25) will be included at the task order level. The task order solicitation will include the appropriate terms and conditions. (iii) All technical data required to respond will be provided as part of the solicitation. (iv) All responsible sources may submit a quotation, bid, or proposal, as appropriate, which will be considered by the agency. (5) Timing. The solicitation is anticipated to be released by November 16, 2026.
-Pre-Solicitation11/08/2026
This is not a solicitation announcement. This is a Sources Sought Notice (SSN) only. This SSN is issued solely for market research and planning purposes – it does not constitute a Request for Quotation (RFQ) or a promise to issue an RFQ in the future. Further, the SSN does not commit the Government to contract for any supply or service whatsoever. The FDA is not seeking proposals and will not accept any unsolicited proposals. Responders are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this SSN; all costs associated with responding to this SSN will be solely at the expense of the interested respondents. Not responding to this SSN does not preclude participation in any future RFQ, if issued. The purpose of this SSN is to gain knowledge of potential qualified vendors, including large business sources, small business sources and their size classifications (i.e., HUBZone 8(a), 8(a), HUBZone, Service-Disabled Veteran-Owned, Veteran-Owned, Women-Owned Small Business, and Small Disadvantaged Business) relative to the North American Industry Classification System (NAICS) code. Responses to this SSN will be used by the Government to make appropriate determinations about potential sources. Project Title: FDA/CDRH Scientific Technical Capacity for Regulatory Review Background: To assist the U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH) in fulfilling its mission, CDRH seeks expert consultants to assist CDRH’s Offices with regulatory review across the total product lifecycle. CDRH requires consultants that have skilled experience to assist with medical device regulatory review work and supporting scientific activities, such as research, cybersecurity and digital health consultations, regulatory consultations and auditing, and interacting with industry and patients. The CDRH requires consultants that have sufficient skilled capacity in many science, engineering, and clinical specialties, including Anesthesiology, Biology, Biomedical Engineering, Chemistry, Clinical laboratory testing, Computer Science and Engineering, Consumer Safety, Cybersecurity, Data Science, Dentistry, Digital Health, Epidemiology, Gastroenterology, General Engineering, Health Science, Infectious Diseases, Interdisciplinary Engineer/Scientist, Molecular testing, Neurology, Optics, Patient Engagement, Physics, Psychiatry, Public Health, Pulmonology, Reprocessing medical devices, Social Scientist, Software Engineering, Statistics and Biostatistics, Sterilization, Toxicology, Urology, Veterinary Medicine, and Virology. Objective: The primary objective of this effort is to provide the CDRH with a vehicle to acquire the support services of advanced professional and scientific consultants to assist CDRH’s Offices with regulatory review across the total product lifecycle, including the supporting scientific, engineering, clinical, and regulatory activities. The services provided will be critical scientific expertise and capacity in support for the evaluation of the continued performance, safety, and effectiveness, with respect to devices approved, cleared, licensed, or authorized for use for the treatment, prevention, or diagnosis of medical conditions by the FDA. Instructions for Responses to this SSN: Your responses to the questions provided below will assist the Government in selecting the appropriate acquisition method. Page limit: Maximum 15 pages (font size Times New Roman 11 or larger). In addition to responses to the below questions, each vendor responding to this SSN shall also fill out and provide responses to “Attachment B-Vendor Feedback Form.” The Vendor Feedback Form is not included in the 15-page limit. A copy of the company capability statement will also be accepted (but not in place of the responses to the below questions or the Vendor Feedback Form). The anticipated period of performance consists of one (1) Base Year and four (4) Option Years. Responses to this SSN must include company name, address, point of contact, size of business pursuant to the NAICS code, and must respond to the following questions: Is your business a small business under the NAICS code? Does your firm qualify as a Small Disadvantaged Business? If disadvantaged, specify if your firm is certified under Section 8(a) of the Small Business Act? Are you considered a certified HUBZone firm? Are you considered Woman-Owned or operated business? Are you a certified Service-Disabled Veteran-Owned or Veteran-Owned business? Included is a draft Statement of Work that is inclusive of the anticipated Task Areas (“Attachment A-Draft Statement of Work”). All interested parties can provide written opinions/questions on the draft Statement of Work. All opinions/questions expressed should focus on strengthening the draft Statement of Work Tasks to ensure industry understands and comprehends the government’s requirements. Responses to this SSN shall be submitted via e-mail to Melinda Kim, Contract Specialist, at Melinda.Kim@fda.hhs.gov, (with a CC: to Nicholas Bisher, Contracting Officer, at Nicholas.Bisher@fda.hhs.gov), by 2:00 PM Eastern Standard Time on November 17, 2026. The subject line of the e-mail shall reference, “Vendor Response to SSN 75F40127Q00006.” After a review of the received responses, a formal solicitation may be published on SAM.gov or on GSA eBuy. No solicitation is currently available. This is not a request for quotation and in no way obligates the Government to award any contract. Responses to this SSN will not be considered adequate responses to the solicitation, a request to be added to a prospective offerors list, or a request to receive a copy of the solicitation. Attachments: Attachment A-Draft Statement of Work Attachment B-Vendor Feedback Form
-Market Research11/17/2026
-Sole Source / J&AOpen
The Centers for Medicare and Medicaid Services seeks information from potential vendors regarding its the Qualified Independent Contractor (QIC) program. Please the attached documents for further details. ------------------------------------------------------------------------------------------------------------------------------------------- 10/19/26 - adding the Technical Questions workbook attachment referenced on page 7 of the RFI document
-Special Notice11/05/2026

Additional Details

Solicitation Number

75D301-23-R-72693

Archive Date

Aug 20, 2023

Office Address

ATLANTA, GA, 30333